📱 Now on iPhone — live scores, valuations & alerts on the go
Create an account for unlimited access
Zenas BioPharma, Inc. (ZBIO)
Healthcare
Model Divergence
stressed
$32.88
Updated: 2026-09-05
23
TradeApes Score
Financial Strength
37
Weak
Operating Trend
0
Stressed
Relative Value
2
Overvalued
Capital Allocation
3
Stressed
Risk Management
59
Mixed
Sector Rank
#4447
The market price implies growth our normalized base can't support, so we don't publish a single fair-value figure for ZBIO.
Key Findings
+
current + quick ratio
−
earnings yield (absolute)
Industry Related Stocks
Get ZBIO and 3,000+ stocks in your pocket
Health scores, fair-value estimates, and full company analysis — free on iPhone.
Download iPhone App
TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor.
The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.
Sign up for our Weekly Sector Leaders Newsletter
11 sector-leading stocks delivered to your inbox every Sunday. Free.
No spam. Unsubscribe anytime.